Biotech news continually updated from thousands of sources around the net.
30 min ago | R & D
Univ. of Washington bioengineers have discovered a potentially faster way to deliver a topical drug that protects women from contracting HIV.
3 hrs ago | CFRA
In this Dec. 6, 2013 file photo, Sarah Davis, left, puts on earmuffs over her hat as John Davis, right, burrows under some blankets, as they try to keep warm in their tent at a homeless encampment in Oklahoma City.
5 hrs ago | Reuters
A new drug being developed by French drugmaker Sanofi and U.S. partner Regeneron cut "bad" LDL cholesterol more than placebo and existing treatments in nine late-stage clinical trials, the companies said on Wednesday.
Sales for the second quarter of ... )--General Cable Corporation , announced today that its Board of Directors appointed Mr. Ned Hall to serve as an independent director of the Company ... )--Wellesley Bancorp, Inc. , the holding company for Wellesley Bank reported net income of $431 thousand an... )--The traditional subsidy model for wireless ... (more)
Biotechnology firm Amgen announced Tuesday that it plans to close its facilities in Colorado and Washington by the end of next year, resulting in the loss of approximately 430 jobs in Boulder County.
Biologic drugmaker Amgen said Tuesday that it will lay off 12 to 15 percent of its worldwide workforce and close four sites, even as it reported very strong second-quarter results that trounced Wall Street expectations.
Drug firm Ranbaxy Laboratories today reported consolidated net loss of Rs 185.92 crore for the quarter ended June 30, 2014.
The potentially Ebola-related death last week of a Liberian government official whose wife and children live in Minnesota has heightened concerns and inspired a fundraising drive to send medical supplies to Liberia.
An outbreak of Ebola in West Africa may seem like a distant threat to many Americans, but it is causing some to cancel travel plans and stirring fear in Minnesota, which has the largest Liberian immigrant population in the United States.
Pfizer's second-quarter earnings plunged 79 per cent from last year, when the world's second-largest drugmaker booked a business spinoff gain of more than $10 billion.
A big one-time gain and a tax benefit helped drugmaker Merck & Co. more than double its second-quarter profit, raise the lower end of its profit forecast and easily top analysts' expectations.
In this Thursday, Feb. 28, 2013 photo, Merck scientist Pascale Nantermet conducts research to discover new HIV drugs in West Point, Pa.
The New York company said Tuesday it earned $2.91 billion, or 45 cents per share, in the quarter.
A Shanghai court says American and British investigators who worked for drug maker GlaxoSmithKline will stand trial Aug. 8 on charges of illegally obtaining information on Chinese citizens.
The East Side towers of the Alexandria Center for Life Science have attracted giant pharmaceutical companies such as Pfizer Inc. and Eli Lilly & Co.
A Danbury company researching better ways to treat diabetes has expanded its funding sources through a stock sale agreement with an investment firm.
Targacept CEO Dr. Stephen Hill says the company is considering how best to make use of its resources after the latest in a string of clinical trial failures.
Updated: Wed Jul 30, 2014 12:48 pm
Copyright © 2014 Topix LLC